1.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: under 21 at relapse Sponsor: NCI Protocol IDs: POG-9410, POG-SIMAL-8
|
|
2.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: under 18 Sponsor: NCI Protocol IDs: NCI-85-C-62, NCI-T85-0096N, T85-0096
|
|
3.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: 1 to 21 Sponsor: NCI Protocol IDs: POG-8741/42, POG-8741, POG-8742
|
|
4.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: under 31 Sponsor: NCI Protocol IDs: POG-8759
|
|
5.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: EST-1588
|
|
6.
|
Phase: Phase III Type: Treatment Status: Closed Age: not over 30 Sponsor: NCI Protocol IDs: CCG-7921, POG-9351, INT-0133
|
|
7.
|
Phase: Phase III Type: Treatment Status: Completed Age: any age Sponsor: NCI Protocol IDs: GOG-149, GOG-0149
|
|
8.
|
Phase: Phase III Type: Treatment Status: Closed Age: adult Sponsor: NCI Protocol IDs: SWOG-9313, CLB-9394, E-S9313, NCCTG-933051, INT-0137
|
|
9.
|
Phase: Phase III Type: Treatment Status: Closed Age: 15 to 60 Sponsor: Other Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549
|
|
10.
|
Phase: Phase III Type: Treatment Status: Closed Age: any age Sponsor: Other Protocol IDs: HOG-LUN93-2, NCI-V94-0422
|
|
11.
|
Phase: Phase III Type: Treatment Status: Closed Age: 3 to 21 Sponsor: NCI Protocol IDs: POG-9331, CCG-9932, INT-0140
|
|
12.
|
Phase: Phase III Type: Treatment Status: Completed Age: over 15 Sponsor: NCI, Other Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, T94-0040, NCT00002565
|
|
13.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 to 70 Sponsor: Protocol IDs: FRE-FNCLCC-PALSAR-93, NCI-F94-0018
|
|
14.
|
Phase: Phase III Type: Treatment Status: Closed Age: 75 and under Sponsor: Protocol IDs: MRC-LU09, EU-94023
|
|
15.
|
Phase: Phase III Type: Treatment Status: Completed Age: at least 1 + under 20 at diag. Sponsor: NCI Protocol IDs: CCG-1941
|
|
16.
|
Phase: Phase III Type: Treatment Status: Completed Age: 30 and under Sponsor: NCI Protocol IDs: POG-9354, CCG-7942, INT-0154
|
|
17.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MSKCC-95088, RP-56976-TAX-320, NCI-V96-0830
|
|
18.
|
Phase: Phase III Type: Treatment Status: Closed Age: under 15 at initial diagnosis Sponsor: Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039
|
|
19.
|
Phase: Phase III Type: Treatment Status: Closed Age: over 1 and under 15 Sponsor: Protocol IDs: MRC-LEUK-UKALL-XI, EU-95036
|
|
20.
|
Phase: Phase III Type: Treatment Status: Closed Age: any age Sponsor: Protocol IDs: MRC-LU20, EU-95041
|
|
21.
|
Phase: Phase III Type: Health services research, Treatment Status: Completed Age: 16 to 65 Sponsor: Other Protocol IDs: CDR0000064834, IBCSG-15-95, EU-96021, NCT00002784
|
|
22.
|
Phase: Phase III Type: Treatment Status: Closed Age: 16 to 65 Sponsor: Other Protocol IDs: UNMC-35195, NCI-V96-0918
|
|
23.
|
Phase: Phase III Type: Treatment Status: Closed Age: under 21 Sponsor: Protocol IDs: GER-NB90, EU-96004, NCT00002802
|
|
24.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 to 65 Sponsor: NCI Protocol IDs: E-2493, E2493
|
|
25.
|
Phase: Phase III Type: Treatment Status: Closed Age: under 21 Sponsor: NCI Protocol IDs: CCG-1951, NCT00002816
|